Alnylam Pharmaceuticals Inc. (ALNY) Social Stream
ALNYLAM PHARMACEUTICALS INC (ALNY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALNY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 17 | $275 | $108 | $200 | $170.37 | 17.39% |
| 2021-11-22 | 18 | $275 | $108 | $200 | $170.37 | 17.39% |
| 2021-12-29 | 19 | $275 | $108 | $202.5 | $170.37 | 18.86% |
| 2022-01-11 | 19 | $275 | $108 | $203.85 | $170.37 | 19.65% |
| 2022-01-18 | 19 | $275 | $108 | $203.3 | $170.37 | 19.33% |
| 2022-01-23 | 19 | $350 | $108 | $208.3 | $170.37 | 22.26% |
| 2022-01-28 | 18 | $350 | $108 | $208.2 | $170.37 | 22.2% |
| 2022-02-10 | 18 | $350 | $109 | $208.65 | $170.37 | 22.47% |
| 2022-02-14 | 16 | $350 | $103 | $212.052 | $170.37 | 24.47% |
| 2022-02-22 | 15 | $350 | $103 | $214.166 | $170.37 | 25.71% |
| 2022-03-10 | 16 | $350 | $103 | $214.631 | $170.37 | 25.98% |
| 2022-04-04 | 15 | $350 | $103 | $211.277 | $170.37 | 24.01% |
| 2022-04-12 | 15 | $400 | $103 | $214.055 | $170.37 | 25.64% |
| 2022-04-19 | 15 | $400 | $103 | $214.277 | $170.37 | 25.77% |
| 2022-04-25 | 15 | $400 | $103 | $214.277 | $170.37 | 25.77% |
| 2022-04-28 | 15 | $400 | $103 | $212.5 | $170.37 | 24.73% |
| 2022-05-02 | 15 | $430 | $96 | $212.444 | $170.37 | 24.7% |
| 2022-06-06 | 15 | $430 | $96 | $211.888 | $170.37 | 24.37% |
| 2022-06-15 | 16 | $430 | $96 | $211.888 | $170.37 | 24.37% |
| 2022-06-22 | 16 | $430 | $98 | $212.333 | $170.37 | 24.63% |
| 2022-07-22 | 18 | $430 | $97 | $210.157 | $170.37 | 23.35% |
| 2022-07-29 | 18 | $430 | $97 | $209.631 | $170.37 | 23.04% |
| 2022-08-03 | 18 | $430 | $97 | $207.842 | $170.37 | 21.99% |
| 2022-08-04 | 19 | $430 | $155 | $230.277 | $170.37 | 35.16% |
| 2022-08-13 | 19 | $430 | $155 | $233.117 | $170.37 | 36.83% |
| 2022-08-22 | 19 | $430 | $155 | $231.5 | $170.37 | 35.88% |
| 2022-09-17 | 19 | $430 | $155 | $236.5 | $170.37 | 38.82% |
| 2022-10-02 | 19 | $430 | $155 | $237.888 | $170.37 | 39.63% |
| 2022-10-03 | 19 | $430 | $155 | $240.058 | $170.37 | 40.9% |
| 2022-10-07 | 18 | $430 | $155 | $240.058 | $170.37 | 40.9% |
| 2022-10-12 | 18 | $430 | $155 | $239.941 | $170.37 | 40.84% |
| 2022-10-21 | 18 | $430 | $155 | $239.882 | $170.37 | 40.8% |
| 2022-10-24 | 18 | $430 | $155 | $239.647 | $170.37 | 40.66% |
| 2022-10-28 | 18 | $430 | $142 | $238.352 | $170.37 | 39.9% |
| 2022-10-31 | 20 | $430 | $142 | $239.888 | $170.37 | 40.8% |
| 2022-11-02 | 20 | $415 | $142 | $238.894 | $170.37 | 40.22% |
| 2022-12-07 | 20 | $415 | $145 | $239.052 | $170.37 | 40.31% |
| 2022-12-19 | 20 | $415 | $145 | $242.105 | $170.37 | 42.11% |
| 2022-12-23 | 20 | $415 | $145 | $244.263 | $170.37 | 43.37% |
| 2023-01-16 | 20 | $415 | $144 | $244.21 | $170.37 | 43.34% |
| 2023-01-23 | 20 | $415 | $143 | $244.157 | $170.37 | 43.31% |
| 2023-01-25 | 20 | $415 | $143 | $244.684 | $170.37 | 43.62% |
| 2023-01-27 | 20 | $415 | $143 | $244.736 | $170.37 | 43.65% |
| 2023-02-08 | 20 | $415 | $143 | $248.888 | $170.37 | 46.09% |
| 2023-02-21 | 21 | $415 | $143 | $251.789 | $170.37 | 47.79% |
| 2023-02-24 | 22 | $415 | $143 | $252.25 | $170.37 | 48.06% |
| 2023-02-26 | 22 | $415 | $136 | $250.75 | $170.37 | 47.18% |
| 2023-03-03 | 21 | $415 | $136 | $250.55 | $170.37 | 47.06% |
| 2023-03-31 | 22 | $415 | $136 | $250.19 | $170.37 | 46.85% |
| 2023-04-24 | 22 | $415 | $136 | $250.428 | $170.37 | 46.99% |
| 2023-05-05 | 23 | $415 | $136 | $249.045 | $170.37 | 46.18% |
| 2023-05-08 | 23 | $415 | $136 | $248.818 | $170.37 | 46.05% |
| 2023-06-06 | 23 | $415 | $136 | $249.954 | $170.37 | 46.71% |
| 2023-07-24 | 22 | $415 | $136 | $252.523 | $170.37 | 48.22% |
| 2023-07-26 | 22 | $405 | $140 | $252.238 | $170.37 | 48.05% |
| 2023-08-04 | 22 | $405 | $140 | $251.523 | $170.37 | 47.63% |
| 2023-08-07 | 23 | $405 | $141 | $250.095 | $170.37 | 46.8% |
| 2023-08-08 | 23 | $405 | $141 | $250.142 | $170.37 | 46.82% |
| 2023-09-18 | 23 | $405 | $141 | $252.65 | $170.37 | 48.29% |
| 2023-09-29 | 24 | $405 | $134 | $250.523 | $170.37 | 47.05% |
| 2023-10-10 | 24 | $405 | $134 | $247.285 | $170.37 | 45.15% |
| 2023-10-11 | 24 | $395 | $125 | $236.045 | $170.37 | 38.55% |
| 2023-10-16 | 24 | $395 | $125 | $234.545 | $170.37 | 37.67% |
| 2023-10-17 | 24 | $395 | $125 | $233.863 | $170.37 | 37.27% |
| 2023-11-03 | 25 | $395 | $125 | $230.217 | $170.37 | 35.13% |
| 2023-11-06 | 25 | $395 | $135 | $229.608 | $170.37 | 34.77% |
| 2023-11-15 | 25 | $395 | $135 | $229.434 | $170.37 | 34.67% |
The Trend in the Analyst Price Target
Over the past 17 months, ALNY's average price target has gone up $17.55.
Over the past 49 weeks, ALNY's average upside potential has been 27.54%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-19 | 20 | 415 | 145 | 242.105 | 234.07 | 3.43% |
| 2023-01-16 | 20 | 415 | 144 | 244.210 | 235.53 | 3.69% |
| 2023-04-13 | 22 | 415 | 136 | 250.428 | 207.33 | 20.79% |
| 2023-08-07 | 23 | 405 | 141 | 250.142 | 184.29 | 35.73% |
| 2023-11-08 | 25 | 395 | 135 | 229.434 | 169.40 | 35.44% |
ALNY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.68 | 15 | 3 | 7 | 0 | 0 | 25 |
The Trend in the Broker Recommendations
Over the past 17 months, ALNY's average broker recommendation rating worsened by 0.18.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, ALNYLAM PHARMACEUTICALS INC's average analyst price target is greater than 7570.9% of them.
- In the context of Pharmaceutical Products stocks, ALNYLAM PHARMACEUTICALS INC's number of analysts covering the stock is higher than 7874.8% of them.
- In terms of how ALNYLAM PHARMACEUTICALS INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -7549.82% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ALNYLAM PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1977.03% of them.
In the Pharmaceutical Products industry, UTHR, BMRN, and NKTR are the three stocks most similar to ALNYLAM PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ALNY a Buy, Hold or Sell? See the POWR Ratings now!